Sara J Cromer is an expert in Endocrinology at Massachusetts General Hospital (United States). Sara J Cromer has authored 90 publications, the most recent in 2026, and is an investigator in 3 clinical trials. SLR score: 331 (community average: 125). How the SLR is computed.

LeadR Profile

Sara J Cromer Massachusetts General Hospital United States
331 ScienceLeadR Reputation 331
Network Map

Endocrinology

Subspecialties: Internal Medicine - Public Health - Gastroenterology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2015 - 2026

Source: PubMed

Massachusetts General Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 90

Citations

Citations: 1 146 1st author: 28 Last author: 3 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Electronic Health Record-Based Algorithms May Improve Identification of Cases of Atypical Diabetes, Including in Groups Underrepresented in Biomedical Research.
PMID 42892882 — diabetes mellitus, biomedical research, phenotype, algorithms, electronic health records, research, records, demography, diabetes mellitus, type 2
Diabetes Obes Cardiometab CARE20260
Effects of Empagliflozin on Cardiovascular Outcomes Are Consistent Across Sociodemographic Subgroups: A Real-World Analysis From the EMPRISE Study.
PMID 42765974 — diabetes mellitus, mortality, incidence, aged
Diabetes Care20260
Letter to the Editor re: Wu Q and Jung J. Uncovering Racial and Genetic Disparities in FRAX Performance for Fracture Risk Assessment in Postmenopausal Women. JBMR 2025.
PMID 42734294 — risk assessment
J Bone Miner Res20260
Comparative Short-term Risk of Severe Gastrointestinal Events Associated With Opioid Type Among Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists.
PMID 42684335 — diabetes mellitus, glucagon-like peptide 1, glucagon-like peptide-1 receptor, oxycodone, constipation, glucagon, tramadol, therapeutics, hydrocodone, gastroparesis, glucagon-like peptides
Diabetes Care20260
Beyond Glycemia: Entering the Era of Hard Outcomes for Continuous Glucose Monitoring.
PMID 42623545 — diabetes mellitus, continuous glucose monitoring
Diabetes Care20260

Clinical Studies 3

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 2
Phase 3 1

By status:

Completed 3

By type:

Interventional 3

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 1
multicentric5to9 1
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 3

LeadR Networks

Main global connection map